Related Experiment Video
Updated: Jun 21, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
The management of hypertension in hemodialysis and CAPD patients
1General Hospital of Katerini, Katerini, Greece. malliara@hol.gr
Insights
Hypertension management in dialysis patients is crucial for preventing cardiovascular disease. Achieving dry weight and limiting sodium intake, alongside recommended medications, helps control blood pressure and improve outcomes.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) frequently progresses to end-stage renal disease (ESRD), with approximately 86% of patients diagnosed with hypertension.
- Hypertension is a significant risk factor for cardiovascular disease (CVD), the primary cause of morbidity and mortality in the dialysis population.
Purpose of the Study:
- To review the management strategies for hypertension in patients undergoing hemodialysis.
- To emphasize the importance of blood pressure control for reducing cardiovascular risk in ESRD patients.
Main Methods:
- Review of current literature and clinical guidelines on hypertension management in dialysis patients.
- Discussion of pathophysiological determinants, therapeutic targets, and pharmacological interventions.
Main Results:
- Optimal pre- and post-dialysis blood pressure is recommended below 140/90 mmHg.
- Extracellular volume expansion is a key factor in dialysis-related hypertension.
- Angiotensin II receptor antagonists, beta blockers, and calcium channel blockers are recommended first-line antihypertensive drugs.
Conclusions:
- Effective management of hypertension in hemodialysis patients requires addressing extracellular volume and sodium intake.
- Antihypertensive drug therapies are essential for the majority of hemodialysis patients, with beta blockers and calcium channel blockers offering protective cardiovascular benefits.
Abstract:
Patients with chronic kidney disease progress to end stage renal disease and about 86% are diagnosed hypertensives. Hypertension is a risk factor for cardiovascular disease which is the main cause of morbidity and mortality in the dialysis population. Pre and post-dialysis blood pressure values of <140/90 mmHg are recommended as the optimal blood pressure. The extra-cellular volume (ECV) expansion is the main pathophysiological determinant of hypertension in dialysis patients. The efforts should be made to correctly estimate and achieve the patients dry body weigh and to limit dietary sodium intake. Angiotensin II receptor antagonists, beta blockers and calcium channel blockers are recommended as first choice drugs. Beta blockers and calcium channel blockers have been associated with reduced cardiovascular mortality and give their protective effects in patients at high risk. Antihypertensive drug therapies can effectively reduce blood pressure and are needed by the vast majority of hemodialysis patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis III: Nursing Management
Hypertension V: Nursing Management